GILD – Gilead Sciences Inc
Gilead Sciences, Inc., is a pharmaceutical and biotechnology company focusing on antiviral drugs to treat HIV, hepatitis B, hepatitis C, and influenza, notably producing and commercializing the blockbuster drugs Harvoni and Sovald. Besides, Gilead conducts research to develop a pipeline of new drugs and treatments and it also considers the acquisition of other blockbuster drugs.
Website: gilead.com – Market Cap.: $ 90.2 Billion – Stock symbol: GILD
If you want to know more about GILD, click here to review the article written by our investment team.